Login

Morepen Laboratories Ltd.

₹61.5

Overview Charts Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Corp. Action Documents
Consolidated
Standalone

Morepen Laboratories Ltd.

  • NSE : MOREPENLAB

₹61.5

₹61.5

1.34 (2.23%) - 20 Jun 2025 04:25 PM
  • NSE : MOREPENLAB

About Company

Morepen Laboratories is engaged in the manufacturing and sale of APis/ Bulk Drugs, Home Diagnostics, Formulations and OTC products. The plant at Masulkhana is for manufacture of Loratadine, an anti-allergy drug - internationally known as Claritin. Diagnostics business, Morepen has a formidable presence in Blood Glucose Monitors and Blood Pressure Monitors, in the domestic markets.

Market Cap. ₹ 3,370 Cr.
52 Week - High/Low ₹ 101/42
P/E Ratio 32.37
P/B Ratio 3.79
Enterprise Value ₹ 3,357 Cr.
ROE % 13.29
RSI Value 26.88
EMA 50 61.51
EMA 200 62.17
Market Cap. ₹ 3,370 Cr.
52 Week - High/Low ₹ 101/42
P/E Ratio 27.83
P/B Ratio 3.98
Enterprise Value ₹ 3,362 Cr.
ROE % 12.08
RSI Value 26.88
EMA 50 61.51
EMA 200 62.17
Add Parameters

Growth

Valuation

Calculators

Peer Comparison

Industry - Pharmaceuticals & Drugs

* Please refer to the Standalone data if Consolidated financial data for the company is not available.

Shareholding Pattern Numbers in percentages

Insight market
Terms | Privacy | Contact Us
Copyright © 2025 All rights reserved with INVESMATE INSIGHTS PRIVATE LIMITED | All logos and Trademarks registered with their respective owners.